Evaluating Choice of Biologics for Isolated Small-Bowel Crohn’s Disease
- 3 December 2025
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 32 (3) , 572-575
Abstract
Lay Summary: In this study we evaluated the effectiveness of vedolizumab (anti-integrin) vs ustekinumab/risankizumab (anti-interleukin) therapy for isolated small-bowel Crohn’s disease using a real-world, multicenter national database. We found that anti-interleukin therapy was more effective for inducing steroid-free remission and reducing hospitalizations.Keywords
Funding Information
- Pfizer
- AbbVie
This publication has 12 references indexed in Scilit:
- Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s DiseaseNew England Journal of Medicine, 2024
- Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn’s Disease (Versus-CD): Data from the ENEIDA RegistryJournal of Crohn's and Colitis, 2023
- Real-World Evidence Comparing Vedolizumab and Ustekinumab in Antitumor Necrosis Factor-Experienced Patients With Crohn's DiseaseAmerican Journal of Gastroenterology, 2022
- Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysisGut, 2022
- A Systematic Review of Crohn’s Disease Case Definitions in Administrative or Claims DatabasesInflammatory Bowel Diseases, 2022
- Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapyAlimentary Pharmacology & Therapeutics, 2021
- Should We Divide Crohn’s Disease Into Ileum-Dominant and Isolated Colonic Diseases?Clinical Gastroenterology and Hepatology, 2019
- Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C TrialGut, 2019
- Predictors of Durability of Radiological Response in Patients With Small Bowel Crohn’s DiseaseInflammatory Bowel Diseases, 2018
- Colonic Crohn’s Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic DiseaseDigestive Diseases and Sciences, 2018